| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 2Q6R3259KS |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C21H35Cl2MnN5 |
| Molecular Weight | 483.39 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | SOD mimic (antioxidant) | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypotension | 1 | D007022 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3544979 |
| FDA SRS | 2Q6R3259KS |
| PubChem | 6918487 |
CONTENTS